Zymeworks (ZYME) Long-Term Investments (2021 - 2026)

Zymeworks has disclosed Long-Term Investments across 6 years of filings, most recently posting $39.1 million for Q1 2026.

• Long-Term Investments for Q1 2026 came in at $39.1 million, down 30.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.1 million (down 30.55% YoY), and the FY2025 annual result was $41.8 million, down 57.55% from the prior year.
• Long-Term Investments came in at $39.1 million for Q1 2026 at Zymeworks, down from $41.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $98.4 million in Q4 2024 to a low of $886000.0 in Q3 2022.
• The 5-year median for Long-Term Investments is $65.8 million (2024), against an average of $59.9 million.
• Across the five-year window, Long-Term Investments soared 10698.42% in 2023 and slumped 57.55% in 2025, its largest moves.
• Zymeworks' Long-Term Investments stood at $886000.0 in 2022, then jumped by 9147.18% to $81.9 million in 2023, then climbed by 20.14% to $98.4 million in 2024, then slumped by 57.55% to $41.8 million in 2025, then declined by 6.39% to $39.1 million in 2026.
• The last three Long-Term Investments figures came in at $39.1 million (Q1 2026), $41.8 million (Q4 2025), and $47.4 million (Q3 2025), per Business Quant data.